Brokerages Set Bilfinger SE (GBF) Target Price at $42.50

Bilfinger SE (ETR:GBF) has been given an average rating of “Hold” by the nine ratings firms that are covering the stock, MarketBeat.com reports. Two research analysts have rated the stock with a sell rating, four have given a hold rating and three have issued a buy rating on the company. The average twelve-month price target among brokerages that have covered the stock in the last year is €42.50 ($49.42).

Several equities analysts have recently weighed in on the stock. Commerzbank set a €53.00 ($61.63) price target on shares of Bilfinger and gave the stock a “buy” rating in a research note on Tuesday, August 14th. Kepler Capital Markets set a €38.50 ($44.77) price target on shares of Bilfinger and gave the stock a “neutral” rating in a research note on Tuesday, August 21st. HSBC set a €54.00 ($62.79) price target on shares of Bilfinger and gave the stock a “buy” rating in a research note on Wednesday, July 4th. Independent Research set a €43.00 ($50.00) price target on shares of Bilfinger and gave the stock a “neutral” rating in a research note on Wednesday, August 15th. Finally, DZ Bank reissued a “buy” rating on shares of Bilfinger in a research note on Tuesday, August 14th.

GBF opened at €36.76 ($42.74) on Tuesday. Bilfinger has a 52-week low of €32.89 ($38.24) and a 52-week high of €41.14 ($47.84).

About Bilfinger

Bilfinger SE provides engineering and other industrial services to customers in the process industry. The company operates through two segments, Engineering & Technologies (E&T); and Maintenance, Modifications, & Operations (MMO). The E&T segment provides consulting, engineering, manufacturing, and assembly services for industrial facilities.

Read More: Preferred Stock

Analyst Recommendations for Bilfinger (ETR:GBF)

Receive News & Ratings for Bilfinger Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bilfinger and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply